"Breakthrough Antibiotic Zosurabalpin Targets Drug-Resistant Superbugs"
Swiss scientists have discovered a new antibiotic, zosurabalpin, which is effective against drug-resistant gram-negative bacteria, particularly Acinetobacter baumannii. This antibiotic works by blocking the lipopolysaccharide (LPS) responsible for the bacteria's protective outer membrane, causing the bacteria to die. Zosurabalpin represents the first new class of antibiotic against these bacteria in over 50 years and is currently undergoing phase 1 clinical trials. The breakthrough is significant as antimicrobial resistance is projected to cause more deaths than cancer in the next 30 years, and this discovery could lead to the development of more drugs to combat resistant bacteria.